Industry
Medical - Pharmaceuticals
China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2021, it had 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 4 drugstores. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.
Loading...
Open
2.05
Mkt cap
15M
Volume
11K
High
2.20
P/E Ratio
-0.75
52-wk high
5.00
Low
2.05
Div yield
N/A
52-wk low
1.34
Portfolio Pulse from Henry Khederian
April 29, 2024 | 4:29 pm
Portfolio Pulse from Benzinga Newsdesk
April 29, 2024 | 1:03 pm
Portfolio Pulse from Benzinga Newsdesk
April 29, 2024 | 1:01 pm
Portfolio Pulse from Benzinga Newsdesk
March 19, 2024 | 8:12 pm
Portfolio Pulse from Avi Kapoor
March 05, 2024 | 1:06 pm
Portfolio Pulse from Benzinga Newsdesk
March 01, 2024 | 12:50 am
Portfolio Pulse from Benzinga Newsdesk
February 28, 2024 | 6:20 pm
Portfolio Pulse from Benzinga Newsdesk
February 27, 2024 | 10:41 pm
Portfolio Pulse from Benzinga Insights
February 08, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Insights
January 26, 2024 | 9:31 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.